<?xml version="1.1" encoding="UTF-8" standalone="yes"?><xml><head><creation_date>D:20190613172409+02'00'</creation_date><modification_date>D:20190613172801+02'00'</modification_date><initial_authorization>True</initial_authorization><pdf_file>EU-1-04-286_h_epar-other_0.pdf</pdf_file></head><body><section><header>official address  domenico scarlattilaan 6  ●  1083 hs amsterdam  ●  the netherlands an agency of the european union   address for visits and deliveries  refer to www.ema.europa.eu/how-to-find-us  send us a question  go to www.ema.europa.eu/contact  telephone +31 (0)88 781 6000  wilzin procedural steps taken and scientific information after the authorisation application number 
 scope 
 opinion/ 
 notification
 1 issued on commission 
 decision 
 issued
 2 / amended 
 on 
 product 
 information 
 affected
 3 summary ig/1085/g this was an application for a group of variations.
   a.1 - administrative change - change in the name 
 and/or address of the mah
  a.5.a - administrative change - change in the name 
 and/or address of a manufacturer/importer 
 responsible for batch release
  a.5.a - administrative change - change in the name 
 and/or address of a manufacturer/importer 
 16/05/2019 
  
 smpc, annex 
 ii, labelling 
 and pl 
  
                                                 1 notifications are issued for type i variations and article 61(3) notifications (unless part of a group including a type ii variation or extension application or a worksharing application). opinions are issued for all other procedures. 
 2 a commission decision (cd) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex ii, labelling, package leaflet). the cd is issued within two months of the opinion for variations falling under the scope of article 23.1a(a) of regulation (eu) no. 712/2012, or within one year for other procedures. 
 3 smpc (summary of product characteristics), annex ii, labelling, pl (package leaflet).     wilzin  
 ema/336148/2019
  
 page 2/9 
 responsible for batch release a.5.b - administrative change - change in the name 
 and/or address of a manufacturer/importer of the 
 finished product, including quality control sites 
 (excluding manufacturer for batch release) 
  
 n/0030 
 minor change in labelling or package leaflet not 
 connected with the spc (art. 61.3 notification) 
  
 11/03/2019 
  
 pl 
  
 ia/0029/g 
 this was an application for a group of variations.
   a.7 - administrative change - deletion of 
 manufacturing sites
  a.7 - administrative change - deletion of 
 manufacturing sites
  a.7 - administrative change - deletion of 
 manufacturing sites
  a.7 - administrative change - deletion of 
 manufacturing sites
  b.iii.1.b.2 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - new 
 certificate for a starting 
 material/reagent/intermediate/or excipient from a 
 new or an already approved manufacturer
  b.iii.1.b.2 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - new 
 certificate for a starting 
 material/reagent/intermediate/or excipient from a 
 new or an already approved manufacturer
  b.iii.1.b.2 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - new 
 certificate for a starting 
 14/01/2019 
 n/a 
  
  
     wilzin  
 ema/336148/2019
  
 page 3/9 
 material/reagent/intermediate/or excipient from a new or an already approved manufacturer
  b.iii.1.b.2 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - new 
 certificate for a starting 
 material/reagent/intermediate/or excipient from a 
 new or an already approved manufacturer
  b.iii.1.b.4 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - deletion of 
 certificates (in case multiple certificates exist per 
 material) 
  
 n/0028 
 minor change in labelling or package leaflet not 
 connected with the spc (art. 61.3 notification) 
  
 24/07/2018 
  
 labelling and 
 pl 
  
 psusa/3145/
 201610 
 periodic safety update eu single assessment - zinc 
 acetate dihydrate 
  
 09/06/2017 
 n/a 
  
 prac recommendation - maintenance 
 ig/0773/g 
 this was an application for a group of variations.
   b.ii.b.1.a - replacement or addition of a 
 manufacturing site for the fp - secondary packaging 
 site
  b.ii.b.2.c.1 - change to importer, batch release 
 arrangements and quality control testing of the fp - 
 replacement or addition of a manufacturer 
 responsible for importation and/or batch release - not 
 including batch control/testing 
  
 14/02/2017 
 19/02/2018 
 annex ii and pl 
  
 ia/0025 
 b.ii.d.2.a - change in test procedure for the finished 
 product - minor changes to an approved test 
 procedure 
 08/12/2016 
 n/a 
  
  
     wilzin  
 ema/336148/2019
  
 page 4/9 
  ia/0024 b.ii.d.2.a - change in test procedure for the finished 
 product - minor changes to an approved test 
 procedure 
  
 25/11/2016 
 n/a 
  
  
 ia/0023 
 a.5.b - administrative change - change in the name 
 and/or address of a manufacturer/importer of the 
 finished product, including quality control sites 
 (excluding manufacturer for batch release) 
  
 24/06/2016 
 n/a 
  
  
 ig/0686 
 b.ii.b.1.a - replacement or addition of a 
 manufacturing site for the fp - secondary packaging 
 site 
  
 12/05/2016 
 n/a 
  
  
 ia/0021/g 
 this was an application for a group of variations.
   b.iii.1.b.2 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - new 
 certificate for a starting 
 material/reagent/intermediate/or excipient from a 
 new or an already approved manufacturer
  b.iii.1.b.3 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - updated 
 certificate from an already approved manufacturer
  b.iii.1.b.4 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - deletion of 
 certificates (in case multiple certificates exist per 
 material) 
  
 23/07/2015 
 n/a 
  
  
 ia/0020 
 b.ii.b.4.b - change in the batch size (including batch 
 size ranges) of the finished product - downscaling 
 down to 10-fold 
 12/06/2015 
 n/a 
  
  
     wilzin  
 ema/336148/2019
  
 page 5/9 
  ib/0019 to extend the shelf life of the finished product from 24 
 to 36 months. the mah has also taken the opportunity 
 to update the local representatives in the pil.
   b.ii.f.1.b.1 - stability of fp - extension of the shelf life 
 of the finished product - as packaged for sale 
 (supported by real time data) 
  
 18/05/2015 
 17/05/2016 
 smpc and pl 
  
 iain/0018/g 
 this was an application for a group of variations.
   b.i.a.1.a - change in the manufacturer of as or of a 
 starting material/reagent/intermediate for as - the 
 proposed manufacturer is part of the same 
 pharmaceutical group as the currently approved 
 manufacturer
  b.i.a.1.f - change in the manufacturer of as or of a 
 starting material/reagent/intermediate for as - 
 changes to quality control testing arrangements for 
 the as -replacement or addition of a site where batch 
 control/testing takes place 
  
 15/04/2015 
 n/a 
  
  
 ib/0017 
 b.ii.c.2.d - change in test procedure for an excipient - 
 other changes to a test procedure (including 
 replacement or addition) 
  
 10/03/2015 
 n/a 
  
  
 ig/0535 
 c.i.8.a - introduction of or changes to a summary of 
 pharmacovigilance system - changes in qppv 
 (including contact details) and/or changes in the psmf 
 location 
  
 06/03/2015 
 n/a 
  
  
     wilzin  
 ema/336148/2019
  
 page 6/9 
 ia/0015/g this was an application for a group of variations.
   b.ii.c.2.a - change in test procedure for an excipient - 
 minor changes to an approved test procedure
  b.ii.c.2.a - change in test procedure for an excipient - 
 minor changes to an approved test procedure
  b.ii.c.3.a.1 - change in source of an excipient or 
 reagent with tse risk - from tse risk material to 
 vegetable or synthetic origin - for excipients or 
 reagents not used in the manufacture of a 
 biol/immunol as or in a biol/immunol medicinal 
 product
  b.iii.1.b.2 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - new 
 certificate for a starting 
 material/reagent/intermediate/or excipient from a 
 new or an already approved manufacturer
  b.iii.1.b.3 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - updated 
 certificate from an already approved manufacturer
  b.iii.1.b.4 - submission of a new/updated or deletion 
 of ph. eur. tse certificate of suitability - deletion of 
 certificates (in case multiple certificates exist per 
 material) 
  
 17/12/2014 
 n/a 
  
  
 ig/0393 
 c.i.8.a - introduction of or changes to a summary of 
 pharmacovigilance system - changes in qppv 
 (including contact details) and/or changes in the psmf 
 location 
  
 20/12/2013 
 n/a 
  
  
 ig/0392 
 b.ii.b.2.c.1 - change to importer, batch release 
 arrangements and quality control testing of the fp - 
 19/12/2013 
 29/01/2014 
 annex ii and pl 
  
     wilzin  
 ema/336148/2019
  
 page 7/9 
 replacement or addition of a manufacturer responsible for importation and/or batch release - not 
 including batch control/testing 
  
 ib/0011/g 
 this was an application for a group of variations.
   b.ii.b.1.b - replacement or addition of a 
 manufacturing site for the fp - primary packaging site
  b.ii.b.1.e - replacement or addition of a 
 manufacturing site for the fp - site where any 
 manufacturing operation(s) take place, except 
 batch-release, batch control, primary and secondary 
 packaging, for non-sterile medicinal products
  b.ii.b.2.a - change to importer, batch release 
 arrangements and quality control testing of the fp - 
 replacement/addition of a site where batch 
 control/testing takes place 
  
 13/12/2013 
 n/a 
  
  
 ia/0012 
 a.4 - administrative change - change in the name 
 and/or address of a manufacturer or an asmf holder 
 or supplier of the as, starting material, reagent or 
 intermediate used in the manufacture of the as or 
 manufacturer of a novel excipient 
  
 14/11/2013 
 n/a 
  
  
 ib/0010 
 c.i.3.a - implementation of change(s) requested 
 following the assessment of an usr, class labelling, a 
 psur, rmp, fum/so, data submitted under a 45/46, 
 or amendments to reflect a core spc - changes with 
 no new additional data are submitted by the mah 
  
 17/01/2013 
 29/01/2014 
 smpc and pl 
  
 n/0009 
 minor change in labelling or package leaflet not 
 connected with the spc (art. 61.3 notification) 
 12/09/2012 
 29/01/2014 
 pl 
  
     wilzin  
 ema/336148/2019
  
 page 8/9 
  n/0008 minor change in labelling or package leaflet not 
 connected with the spc (art. 61.3 notification) 
  
 23/01/2012 
 29/01/2014 
 pl 
  
 ib/0007 
 b.ii.d.1.g - change in the specification parameters 
 and/or limits of the finished product - addition or 
 replacement (excluding biological or immunological 
 product) of a specification parameter as a result of a 
 safety or quality issue 
  
 28/07/2010 
 n/a 
  
  
 ib/0006 
 ib_12_a_change in spec. of active subst./agent used 
 in manuf. of active subst. - tightening
  ib_12_b_01_change in spec. of active subst./agent in 
 manuf. of active subst. - test parameter as
  ib_25_a_01_change to comply with ph. - compliance 
 with eu ph. - active substance 
  
 20/01/2010 
 n/a 
  
  
 r/0005 
 renewal of the marketing authorisation. 
  
 23/07/2009 
 19/10/2009 
 smpc, annex 
 ii, labelling 
 and pl 
 based on the review of the available information the chmp is 
 of the opinion that the quality, the safety and the efficacy of 
 this medicinal product continues to be adequately and 
 sufficiently demonstrated and therefore considers that the 
 benefit/risk profile continues to be favourable. the chmp 
 was also of the opinion that the renewal can be granted with 
 unlimited validity. 
 ia/0004 
 ia_01_change in the name and/or address of the 
 marketing authorisation holder
  ia_05_change in the name and/or address of a 
 manufacturer of the finished product 
  
 06/09/2007 
 n/a 
 smpc, annex 
 ii, labelling 
 and pl 
  
 ia/0002 
 ia_36_ b_change in shape or dimensions of the 
 container/closure - other pharm. forms 
 06/06/2007 
 n/a 
  
  
     wilzin  
 ema/336148/2019
  
 page 9/9 
  ia/0001 ia_07_a_replacement/add. of manufacturing site: 
 secondary packaging site 
  
 12/05/2006 
 n/a</header></section></body></xml>